The company has received US Food and Drug Administration final approval for its ANDA, Docetaxel Injection USP, 20 mg/mL, 80 mg/4 mL (20 mg/mL), and 160 mg/8 mL (20 mg/mL).
Shares of Hindalco Industries fell more than 2 percent after the company reported a 17.9 percent YoY decline in profit for the quarter ended March 2019 at Rs 506 crore, compared to Rs 616 crore in the year-ago period.
CESC Ventures reported 75.7 percent decline in net profit for the quarter ended March 2019 at Rs 9 crore, compared to Rs 37 crore in the year-ago period. Revenue is up 9 percent at Rs 1,096 crore, against Rs 1,004 crore in the corresponding quarter last year.
FMCG stocks are trading in the positive, up 1.96 percent on Nifty. All constituent stocks except P&G Hygiene and Health Care and Emami are trading in the green. Godrej Consumer Products is the biggest gainer, up 4.4 percent. Emami is the biggest loser, down 1.91 percent on Nifty.
The benchmark indices are trading higher on May 17 with Nifty around 11,350 level.
At 12:15 hrs IST, the Sensex is up 333.33 points or 0.89% at 37726.81, and the Nifty up 88.40 points or 0.79% at 11345.50. About 1119 shares have advanced, 966 shares declined, and 121 shares are unchanged.